Literature DB >> 30218409

Laboratory automation reduces time to report of positive blood cultures and improves management of patients with bloodstream infection.

Giuseppe Vittorio De Socio1, Francesco Di Donato2, Riccardo Paggi2, Chiara Gabrielli1, Alessandra Belati2, Giuseppe Rizza3, Martina Savoia3, Antonella Repetto4, Elio Cenci2, Antonella Mencacci5.   

Abstract

The impact on time to results (TTR) and clinical decisions was evaluated for mono-microbial positive blood cultures (BC) processed using the BD Kiestra Work Cell Automation (WCA) system. Positive BC were processed by the WCA system by full-automatic subculture on solid media and digital imaging after 8 h of incubation (8-h method) followed by identification (ID) and antimicrobial susceptibility testing (AST). To evaluate the accuracy of the 8-h method, ID and AST from 8-h and overnight incubated colonies were compared for the same organisms. To evaluate its clinical impact, results from 102 BC processed by the 8-h method (cases) were compared with those from 100 BC processed by overnight incubation method (controls) in a comparable period. Identification after 8-h and overnight incubation gave concordant results in 101/102 (99.0%) isolates. Among a total of 1379 microorganism-antimicrobial combinations, categorical agreement was 99.4% (1371/1379); no very major error, 7 major errors, and one minor error were observed. TTR in cases (32.8 h ± 8.3 h) was significantly (p < 0.001) shorter than in controls (55.4 h ± 13.3 h). A significant reduction was observed for duration of empirical therapy (cases 54.8 h ± 23.3 h vs controls 86.9 h ± 34.1 h, p < 0.001) and 30-day crude mortality rate (cases 16.7% vs controls 29.0%, p < 0.037). Automation and 8-h digital reading of plates from positive BC, followed by ID and AST, greatly reduce TTR and shorten the duration of antimicrobial empiric therapy, possibly improving outcome in patients with mono-microbial bloodstream infections.

Entities:  

Keywords:  BD Kiestra; Blood culture; Bloodstream infections; Laboratory automation; Time to report

Mesh:

Substances:

Year:  2018        PMID: 30218409     DOI: 10.1007/s10096-018-3377-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  How could rapid bacterial identification improve the management of septic patients?

Authors:  Stéphane Emonet; Jacques Schrenzel
Journal:  Expert Rev Anti Infect Ther       Date:  2011-09       Impact factor: 5.091

2.  How small modifications in laboratory workflow of blood cultures can have a significant impact on time to results.

Authors:  B Van den Poel; A Klak; S Desmet; J Verhaegen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-30       Impact factor: 3.267

3.  Blood Culture Turnaround Time in U.S. Acute Care Hospitals and Implications for Laboratory Process Optimization.

Authors:  Ying P Tabak; Latha Vankeepuram; Gang Ye; Kay Jeffers; Vikas Gupta; Patrick R Murray
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

4.  Rapid identification of microorganisms from positive blood cultures by MALDI-TOF mass spectrometry subsequent to very short-term incubation on solid medium.

Authors:  E A Idelevich; I Schüle; B Grünastel; J Wüllenweber; G Peters; K Becker
Journal:  Clin Microbiol Infect       Date:  2014-05-15       Impact factor: 8.067

5.  Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.

Authors:  J Rello; T S R van Engelen; E Alp; T Calandra; V Cattoir; W V Kern; M G Netea; S Nseir; S M Opal; F L van de Veerdonk; M H Wilcox; W J Wiersinga
Journal:  Clin Microbiol Infect       Date:  2018-03-24       Impact factor: 8.067

6.  Transformation From a Conventional Clinical Microbiology Laboratory to Full Automation.

Authors:  José L Moreno-Camacho; Diana Y Calva-Espinosa; Yoseli Y Leal-Leyva; Dolores C Elizalde-Olivas; Abraham Campos-Romero; Jonathan Alcántar-Fernández
Journal:  Lab Med       Date:  2017-12-22

7.  Identification by mass spectrometry and automated susceptibility testing from positive bottles: a simple, rapid, and standardized approach to reduce the turnaround time in the management of blood cultures.

Authors:  Carola Mauri; Luigi Principe; Silvia Bracco; Elisa Meroni; Nicoletta Corbo; Beatrice Pini; Francesco Luzzaro
Journal:  BMC Infect Dis       Date:  2017-12-06       Impact factor: 3.090

8.  A fresh look at polymicrobial bloodstream infection in cancer patients.

Authors:  Cristina Royo-Cebrecos; Carlota Gudiol; Carmen Ardanuy; Helena Pomares; Mariona Calvo; Jordi Carratalà
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

9.  Detection of MRSA in nasal swabs-marked reduction of time to report for negative reports by substituting classical manual workflow with total lab automation.

Authors:  Irene Burckhardt; Susanne Horner; Florian Burckhardt; Stefan Zimmermann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-25       Impact factor: 3.267

10.  Performance of Kiestra total laboratory automation combined with MS in clinical microbiology practice.

Authors:  Nico T Mutters; Caspar J Hodiamont; Menno D de Jong; Hendri P J Overmeijer; Mandy van den Boogaard; Caroline E Visser
Journal:  Ann Lab Med       Date:  2014-02-13       Impact factor: 3.464

View more
  3 in total

Review 1.  Consolidation of Clinical Microbiology Laboratories and Introduction of Transformative Technologies.

Authors:  Zisis Kozlakidis; Alex van Belkum; Olivier Vandenberg; Géraldine Durand; Marie Hallin; Andreas Diefenbach; Vanya Gant; Patrick Murray
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

Review 2.  Laboratory Automation in Clinical Microbiology.

Authors:  Irene Burckhardt
Journal:  Bioengineering (Basel)       Date:  2018-11-22

3.  Evaluation of EUCAST rapid antimicrobial susceptibility testing (RAST) for positive blood cultures in clinical practice using a total lab automation.

Authors:  Jasmin Kaur Jasuja; Stefan Zimmermann; Irene Burckhardt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-02-28       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.